X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mycophenolic acid - analogs & derivatives (5663) 5663
humans (5417) 5417
mycophenolic acid - therapeutic use (3751) 3751
immunosuppressive agents - therapeutic use (3344) 3344
male (3324) 3324
female (3200) 3200
transplantation (2603) 2603
adult (2518) 2518
middle aged (2399) 2399
surgery (1892) 1892
immunology (1637) 1637
mycophenolate mofetil (1627) 1627
drug therapy, combination (1519) 1519
mycophenolic acid - administration & dosage (1302) 1302
treatment outcome (1274) 1274
immunosuppressive agents - adverse effects (1199) 1199
immunosuppressive agents - administration & dosage (1124) 1124
mycophenolic acid - adverse effects (1092) 1092
aged (1066) 1066
cyclosporine - therapeutic use (1019) 1019
kidney transplantation (969) 969
cyclosporine (947) 947
graft rejection - prevention & control (936) 936
tacrolimus - therapeutic use (930) 930
kidney transplantation - immunology (922) 922
animals (895) 895
adolescent (809) 809
mycophenolic acid - pharmacology (803) 803
tacrolimus (794) 794
time factors (785) 785
retrospective studies (782) 782
immunosuppression (749) 749
follow-up studies (669) 669
recipients (657) 657
therapy (651) 651
mycophenolate-mofetil (637) 637
mycophenolic acid - pharmacokinetics (619) 619
azathioprine - therapeutic use (613) 613
child (609) 609
mycophenolic acid (581) 581
urology & nephrology (568) 568
pharmacology & pharmacy (556) 556
immunosuppressive agents - pharmacology (555) 555
immunosuppressive agents - pharmacokinetics (547) 547
prospective studies (517) 517
kidneys (467) 467
calcineurin inhibitors (462) 462
acute rejection (453) 453
rejection (448) 448
pharmacokinetics (443) 443
dose-response relationship, drug (436) 436
acid (416) 416
young adult (408) 408
prednisone - therapeutic use (393) 393
risk factors (391) 391
graft survival (388) 388
mofetil (388) 388
cyclosporine - administration & dosage (384) 384
immunosuppressive agents (383) 383
transplantation, homologous (379) 379
tacrolimus - administration & dosage (374) 374
antibodies, monoclonal - therapeutic use (363) 363
rats (357) 357
prevention (354) 354
sirolimus - therapeutic use (353) 353
graft rejection - drug therapy (349) 349
graft survival - drug effects (336) 336
mycophenolic acid - blood (329) 329
efficacy (325) 325
kidney transplantation - physiology (324) 324
sirolimus (323) 323
kidney transplantation - adverse effects (321) 321
creatinine - blood (319) 319
adrenal cortex hormones - therapeutic use (318) 318
azathioprine (317) 317
kidney-transplantation (317) 317
cyclophosphamide - therapeutic use (316) 316
rheumatology (316) 316
drug administration schedule (315) 315
immunotherapy (313) 313
renal-transplantation (306) 306
lupus nephritis - drug therapy (304) 304
analysis (303) 303
graft rejection - epidemiology (299) 299
child, preschool (298) 298
biopsy (293) 293
graft rejection - immunology (289) 289
disease (287) 287
glucocorticoids - therapeutic use (273) 273
area under curve (271) 271
cyclosporine - adverse effects (267) 267
mycophenolic-acid (261) 261
pediatrics (254) 254
cyclophosphamide (253) 253
prednisolone - therapeutic use (250) 250
tacrolimus - adverse effects (243) 243
immunosuppressive agents - blood (241) 241
acute disease (238) 238
hematology (236) 236
corticosteroids (233) 233
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5952) 5952
Chinese (74) 74
French (69) 69
Spanish (61) 61
German (58) 58
Japanese (57) 57
Polish (19) 19
Portuguese (16) 16
Italian (10) 10
Hungarian (8) 8
Serbian (6) 6
Czech (4) 4
Norwegian (3) 3
Russian (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Lithuanian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 20, pp. 1886 - 1895
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2010, Volume 69, Issue 12, pp. 2083 - 2089
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 6, pp. CD002922 - CD002922
Background Cyclophosphamide, in combination with corticosteroids, has been first‐line treatment for inducing disease remission for proliferative lupus... 
Kidney disease | Glomerular diseases | Recurrence | Immunosuppressive Agents | Glucocorticoids | Calcineurin | Induction Chemotherapy | Chronic kidney disease | Mycophenolic Acid | Randomized Controlled Trials as Topic | Cyclophosphamide | Tacrolimus | Lupus Nephritis | Child health | Glomerular disease | Maintenance Chemotherapy | Azathioprine | Medicine General & Introductory Medical Sciences | LONG-TERM | PULSE INTRAVENOUS CYCLOPHOSPHAMIDE | Induction Chemotherapy [methods] | Mycophenolic Acid [ analogs & derivatives; therapeutic use] | Cyclophosphamide [ therapeutic use] | Humans | ORAL MYCOPHENOLATE-MOFETIL | Lupus Nephritis [ drug therapy] | RANDOMIZED CONTROLLED-TRIAL | CHRONIC PLASMA-EXCHANGE | Azathioprine [therapeutic use] | MAINTENANCE THERAPY | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [therapeutic use] | Immunosuppressive Agents [ therapeutic use] | Maintenance Chemotherapy [methods] | INDUCTION THERAPY | Adult | TERM-FOLLOW-UP | QUALITY-OF-LIFE | Child | STAGE RENAL-DISEASE | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Immunosuppressive Agents - therapeutic use | Induction Chemotherapy - methods | Lupus Nephritis - drug therapy | Male | Tacrolimus - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Maintenance Chemotherapy - methods | Calcineurin - therapeutic use | Female | Immunosuppressive Agents - adverse effects | Azathioprine - adverse effects | Glucocorticoids - adverse effects | Index Medicus
Journal Article